Cannabis Bioscience International Holdings (CBIH) Revenue
Cannabis Bioscience International Holdings Revenue
Cannabis Bioscience International Holdings had a revenue of 11.21K in the quarter ending Feb 28, 2026, with -78.96%. This bring the company's revenue in the last twelve months to 123.63K, Decreased 2.93%. In the fiscal year ending May 31, 2025, Cannabis Bioscience International Holdings had annual revenue of 303.02K with 21.77% growth.
- Revenue (ttm)
- 123.63K
- Revenue Growth
- -64.05%
- P/S Ratio
- 8.06
- Revenue/Employee
- $151,511
- Employees
- 2
- Market Cap
- $2.44M
Revenue Chart
Cannabis Bioscience International Holdings Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 303.02K | 54.18K | 21.77% |
| May 31, 2024 | 248.84K | -67.98K | -21.46% |
| May 31, 2023 | 316.82K | 101.84K | 47.37% |
| May 31, 2022 | 214.98K | -546.76K | -71.78% |
| May 31, 2021 | 761.74K | 181.52K | 31.28% |
| May 31, 2020 | 580.22K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.